Member Info for OAPK20

Looking forward to February and the Athletic range from CBX

https://s1.thcdn.com/design-assets/documents/pureiscbd/CBD%20use%20in%20sport.pdf

Stockists - Boots - Holland and Barret - Planet Organic.

Getting exciting.

https://www.pureiscbd.com/our-story.list

Gives an idea of price ranges. Even the Vegans will be happy. ;-)

Be nice if they started digging pay and generate revenue to fund future drilling.

Our partner increased production by over 400% for initial limited launch. Think on that.
CBX grows, they grow. Peeps being negative about a limited launch before Xmas. Well it’s a perfect storm. The limited launch gives Willow the chance to grow production to even more than greater than 400% to keep up with anticipated demand from full product launch in February 2022.
It also creates the demand. IMO a bit like PS5’s. They sell out as soon as available, everyone wants one, and when PS5 supply increases so do their sells.

IMO DYOR

Gone a bit Quiet. Pumpers sold ?

This is going to be mahooooosive

On the bright side another day closer to first product launch

To be fair to Abbo though profits profit. Good drills.

If you all stop selling/top slicing/trying to trade and just hold, the SP will go up and we’ll all be minted.

Do you suffer from tired, irritated skin or post-shave inflammation ?

Cellular Goods creates science-based formulations that are powered by lab-made CBG, a game-changing ingredient that is set to revolutionise skincare.

By providing safe, engineered products that optimise your wellbeing both inside and out, Cellular Goods is pioneering a new era in everyday routines.

Available from December - sign up for early access
https://www.cellulargoods.co/register

#scienceofwellbeing

FaceBook sterowlands and Instagram

Willow ramping up.

The product from this first run was primarily used for customer samples and to provide material to Cellular Goods PLC ("Cellular Goods") as a part of their June 2021 supply agreement. Since this initial production run, Willow has increased its production titer by >400% and has carried out additional fermentation runs yielding tens of kilograms of ultra-pure CBG at >10,000 L fermentation scale. The Company continues to make significant titer improvements to its strain, with further production runs planned through the end of the year.

Cont.

During the remainder of 2021, Willow said it plans to continue to optimize its commercial process for the rare cannabinoid CBG (cannabigerol), supply product to customers, seed commercial samples to new potential customers, and build out a robust order book for 2022, which the company expects to be its first full year of commercial production and sales.

The company completed its first commercial-scale fermentation run of CBG in 1Q 2021 and signed up its first multi-year commercial agreement with Cellular Goods in 2Q 2021.

“The company has two distinct objectives at this time. The first is to continue to work with larger groups to lock up supply agreements for its biosynthetically produced CBG,” Willow said.

“The second is to continue to advance the development of its portfolio of other cannabinoids to bring them forward to commercialization. While the timing of the first is harder to predict, the company is currently engaged in very promising discussions with interested third parties and believes that its core technology will be significant in helping to enable the more traditional consumer-packaged goods entities enter the cannabinoid space.”

Willow Biosciences closes 3Q with $35.7M in cash while making notable advancements in its operations
For the last three months of 2021, Willow plans to continue to optimize its commercial process for the rare cannabinoid CBG and build out a robust order book for 2022, which it expects to be its first full year of commercial production and sales.
Willow Biosciences Inc reports that it ended its third quarter on September 30, 2021 with $35.7 million in cash while making notable advancements in its operations.

"We continued to make significant strides forward in the third quarter and are well positioned to be the global leader in biosynthetically produced cannabinoids," said CEO Trevor Peters in a statement.

"From our vantage point, we can see the larger players in the consumer-packaged goods ecosystem becoming increasingly more bullish on the health and wellness aspects of the cannabis industry. It has been our view all along that these entities need an ultra-pure, sustainably sourced ingredient supply to meet their long-term demands, and Willow's technology platform enables their entrance into this space."

Until early December…..20 days.

The skincare and ingestible product ranges will be available to purchase from early December 2021 accompanied by a comprehensive marketing activation, building to a full omni-channel launch at the start of February 2022.

At least one LR trade to show up.

Fully loaded up when the sp was in the 6’s but feel free to put your hand in your own pocket

To summarise - Get your shovels

MRE based on around 7.5km surface expression of the total 33 linear km strike length of the potential mineralised zones identified in the 2018 Exploration Target of up to 2 Moz potential within 100 m of surface at Sanankoro (SRK, 2018)

Winkleman or Beckham mmmh